261 related articles for article (PubMed ID: 10609952)
1. Cyclosporine-induced interstitial fibrosis and arteriolar TGF-beta expression with preserved renal blood flow.
Vieira JM; Noronha IL; Malheiros DM; Burdmann EA
Transplantation; 1999 Dec; 68(11):1746-53. PubMed ID: 10609952
[TBL] [Abstract][Full Text] [Related]
2. Macrophage depletion attenuates chronic cyclosporine A nephrotoxicity.
Carlos CP; Mendes GE; Miquelin AR; Luz MA; da Silva CG; van Rooijen N; Coimbra TM; Burdmann EA
Transplantation; 2010 Jun; 89(11):1362-70. PubMed ID: 20535850
[TBL] [Abstract][Full Text] [Related]
3. Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity.
Young BA; Burdmann EA; Johnson RJ; Alpers CE; Giachelli CM; Eng E; Andoh T; Bennett WM; Couser WG
Kidney Int; 1995 Aug; 48(2):439-48. PubMed ID: 7564111
[TBL] [Abstract][Full Text] [Related]
4. Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity.
Shihab FS; Yi H; Bennett WM; Andoh TF
Kidney Int; 2000 Sep; 58(3):1174-85. PubMed ID: 10972680
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine enhances the expression of TGF-beta in the juxtaglomerular cells of the rat kidney.
Shehata M; Cope GH; Johnson TS; Raftery AT; el Nahas AM
Kidney Int; 1995 Nov; 48(5):1487-96. PubMed ID: 8544405
[TBL] [Abstract][Full Text] [Related]
6. Previous exposure to cigarette smoke aggravates experimental cyclosporine-induced nephrotoxicity.
Alves SA; Carlos CP; Mendes GE; Oliveira SM; Luz MA; Souza RP; Matimoto RL; Coimbra TM; Burdmann EA
Am J Nephrol; 2012; 36(4):334-41. PubMed ID: 23018139
[TBL] [Abstract][Full Text] [Related]
7. Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction.
Islam M; Burke JF; McGowan TA; Zhu Y; Dunn SR; McCue P; Kanalas J; Sharma K
Kidney Int; 2001 Feb; 59(2):498-506. PubMed ID: 11168932
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine A sensitizes the kidney to tubulointerstitial fibrosis induced by renal warm ischemia.
Ahmed A; Huang L; Raftery AT; Ahmed AK; Fahmy H; El Nahas AM; Haylor JL
Transplantation; 2004 Mar; 77(5):686-92. PubMed ID: 15021830
[TBL] [Abstract][Full Text] [Related]
9. Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis.
Thomas SE; Andoh TF; Pichler RH; Shankland SJ; Couser WG; Bennett WM; Johnson RJ
Kidney Int; 1998 Apr; 53(4):897-908. PubMed ID: 9551396
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy.
Yang CW; Ahn HJ; Kim WY; Li C; Jung JY; Yoon SA; Kim YS; Cha JH; Kim J; Bang BK
Transplantation; 2003 Feb; 75(3):309-15. PubMed ID: 12589150
[TBL] [Abstract][Full Text] [Related]
11. Expression of transforming growth factor-beta-inducible gene-h3 in normal and cyclosporine-treated rat kidney.
Sun BK; Li C; Lim SW; Jung JY; Lee SH; Kim IS; Kim YS; Kim J; Bang BK; Yang CW
J Lab Clin Med; 2004 Mar; 143(3):175-83. PubMed ID: 15007308
[TBL] [Abstract][Full Text] [Related]
12. Annexin A1 protein attenuates cyclosporine-induced renal hemodynamics changes and macrophage infiltration in rats.
Araujo LP; Truzzi RR; Mendes GE; Luz MA; Burdmann EA; Oliani SM
Inflamm Res; 2012 Mar; 61(3):189-96. PubMed ID: 22101490
[TBL] [Abstract][Full Text] [Related]
13. Pirfenidone treatment decreases transforming growth factor-beta1 and matrix proteins and ameliorates fibrosis in chronic cyclosporine nephrotoxicity.
Shihab FS; Bennett WM; Yi H; Andoh TF
Am J Transplant; 2002 Feb; 2(2):111-9. PubMed ID: 12099512
[TBL] [Abstract][Full Text] [Related]
14. Pentosan polysulfate treatment reduces cyclosporine-induced nephropathy in salt-depleted rats.
Schwedler SB; Bobadilla N; Striker LJ; Vaamonde CA; Herrera-Acosta J; Striker GE
Transplantation; 1999 Nov; 68(10):1583-8. PubMed ID: 10589959
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine withdrawal and mycophenolate mofetil treatment effects on the progression of chronic cyclosporine nephrotoxicity.
Yang CW; Ahn HJ; Kim WY; Li C; Kim HW; Choi BS; Cha JH; Kim YS; Kim J; Bang BK
Kidney Int; 2002 Jul; 62(1):20-30. PubMed ID: 12081560
[TBL] [Abstract][Full Text] [Related]
16. Polymerized type I collagen reduces chronic cyclosporine nephrotoxicity.
Sánchez-Pozos K; Lee-Montiel F; Pérez-Villalva R; Uribe N; Gamba G; Bazan-Perkins B; Bobadilla NA
Nephrol Dial Transplant; 2010 Jul; 25(7):2150-8. PubMed ID: 20139407
[TBL] [Abstract][Full Text] [Related]
17. Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity.
Pérez-Rojas J; Blanco JA; Cruz C; Trujillo J; Vaidya VS; Uribe N; Bonventre JV; Gamba G; Bobadilla NA
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F131-9. PubMed ID: 16835406
[TBL] [Abstract][Full Text] [Related]
18. Effects of cyclosporine in osteopontin null mice.
Mazzali M; Hughes J; Dantas M; Liaw L; Steitz S; Alpers CE; Pichler RH; Lan HY; Giachelli CM; Shankland SJ; Couser WG; Johnson RJ
Kidney Int; 2002 Jul; 62(1):78-85. PubMed ID: 12081566
[TBL] [Abstract][Full Text] [Related]
19. Predictive usefulness of urinary biomarkers for the identification of cyclosporine A-induced nephrotoxicity in a rat model.
Carlos CP; Sonehara NM; Oliani SM; Burdmann EA
PLoS One; 2014; 9(7):e103660. PubMed ID: 25072153
[TBL] [Abstract][Full Text] [Related]
20. Sirolimus increases transforming growth factor-beta1 expression and potentiates chronic cyclosporine nephrotoxicity.
Shihab FS; Bennett WM; Yi H; Choi SO; Andoh TF
Kidney Int; 2004 Apr; 65(4):1262-71. PubMed ID: 15086465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
